Loading...
XSTO
NNH
Market cap7mUSD
Jul 09, Last price  
12.25SEK
1D
0.41%
1Q
-33.78%
Jan 2017
-55.45%
IPO
-75.74%
Name

New Nordic Healthbrands AB

Chart & Performance

D1W1MN
XSTO:NNH chart
P/E
9.26
P/S
0.13
EPS
1.32
Div Yield, %
—
Shrs. gr., 5y
—
Rev. gr., 5y
5.07%
Revenues
576m
+4.73%
201,200,000225,594,000195,302,000199,479,000203,787,000227,983,000271,949,000298,485,000305,842,000344,739,000393,708,000452,613,000450,064,000514,845,000487,501,000533,849,000550,307,000576,364,000
Net income
8m
P
-14,391,000934,000-5,729,000311,000-4,086,0005,781,00012,375,00011,330,0009,574,00020,297,00026,523,00028,074,00017,765,00021,303,000-2,823,000-6,194,000-7,699,0008,195,000
CFO
8m
P
4,859,00010,374,0002,024,000875,0004,167,000483,0003,204,000-2,560,0001,624,00026,420,00017,852,000-667,00019,680,000-7,870,000-15,451,00028,027,000-5,400,0008,387,000
Dividend
Apr 29, 20221.25 SEK/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

New Nordic Healthbrands AB (publ)., engages in providing dietary supplements, natural medicines and cosmetic products for various health and beauty needs in the Nordic countries, Europe, North America, and internationally. The company provides vitality tablets, capsules, and gummy products, including vitamins and minerals, fish oil and Omega-3, and magnesium, as well as for body, sleep and relaxation, menopause, and men health; skincare products comprising dietary supplements, facial care, and body care, as well as assortment products; hair care products, such as hair volume products, dietary supplements, shampoos, conditioners, serum, and other hair care products; and weight loss products. The company sells its products through pharmacies, health stores,beauty stores, and travel retailers, as well as through online stores. New Nordic Healthbrands AB (publ) was founded in 1990 and is headquartered in Malmö, Sweden.
URL
https://newnordic.se/
IPO date
Jan 23, 2007
Employees
74
Domiciled in
SE
Incorporated in
SE

Valuation

Title
SEK in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT